M. Manns, A. Czaja, and J. Gorham, Diagnosis and management of autoimmune hepatitis, Hepatology, vol.51, issue.6, pp.2193-2213, 2010.
DOI : 10.1002/hep.23584

P. Karran and N. Attard, Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer, Nature Reviews Cancer, vol.19, issue.1, pp.24-36, 2008.
DOI : 10.1111/j.1365-2133.2004.06323.x

E. Hennes, Y. Oo, and C. Schramm, Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis?, The American Journal of Gastroenterology, vol.5, issue.12, pp.3063-3070, 2008.
DOI : 10.1155/2004/504591

P. Richardson, P. James, and S. Ryder, Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine, Journal of Hepatology, vol.33, issue.3, pp.371-375, 2000.
DOI : 10.1016/S0168-8278(00)80271-8

D. Van-asseldonk, B. Jharap, and J. Verheij, The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease, Inflammatory Bowel Diseases, vol.22, issue.9, pp.2112-2120, 2016.
DOI : 10.1097/MEG.0b013e3283360021

D. Boer, N. Tuynman, H. Bloemena, and E. , Histopathology of liver biopsies from a thiopurine-na??ve inflammatory bowel disease cohort: Prevalence of nodular regenerative hyperplasia, Scandinavian Journal of Gastroenterology, vol.33, issue.5, pp.604-608, 2008.
DOI : 10.1080/00365529850166806

S. Hübener, Y. Oo, and N. Than, Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.14, issue.3, pp.445-453, 2016.